SCHEMBL14812412

SCHEMBL14812412

COC(=O)Oc1ccc(C(C)=O)c(OC(=O)OC)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.51
▸ MAPT P10636 4/20 0.50
▸ KMT2A Q03164 4/20 0.50
▸ HPGD P15428 3/20 0.50
▸ ALDH1A1 P00352 3/20 0.50
▸ MEN1 O00255 3/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ MAPK1 P28482 3/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ ELANE P08246 3/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ GLA P06280 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ TP53 P04637 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ PKM P14618 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14812604 0.81 HPGDS (0.43) KDM4EMAPTHPGDRAB9AMAPK1
SCHEMBL10958446 0.81 MAPT (0.62) KDM4EMAPTKMT2AHPGDALDH1A1
SCHEMBL11386187 0.80 KDM4E (0.77) KDM4EMAPTKMT2AHPGDALDH1A1
SCHEMBL28830235 0.77 CA12 (0.57) KDM4EMAPTKMT2AHPGDALDH1A1
SCHEMBL13920473 0.77 KDM4E (0.73) KDM4EMAPTKMT2AHPGDALDH1A1
SCHEMBL12541530 0.77 ALDH1A1 (0.59) KDM4EMAPTKMT2AHPGDALDH1A1
SCHEMBL20215988 0.76 ALDH1A1 (0.59) MAPTKMT2AHPGDALDH1A1MEN1
SCHEMBL31261798 0.76 ALDH1A1 (0.57) KDM4EMAPTKMT2AHPGDALDH1A1
SCHEMBL2944091 0.75 KDM4E (0.47) KDM4EMAPTKMT2AALDH1A1MEN1
SCHEMBL676909 0.74 KMT2A (0.58) KDM4EMAPTKMT2AHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2969027-B1 COMPOSITIONS OF ALKYLAMIDOTHIAZOLES AND FRAGRANCES BEIERSDORF AG (DE) 2020-10-14 — — EP disclosed
EP-3176156-B1 ALKYLAMIDOTHIAZOLES, COSMETIC AND DERMATOLOGICAL PREPARATIONS CONTAINING THEM, AND THEIR USE FOR THE TREATMENT AND PROPHYLAXIS OF UNWANTED PIGMENTATION OF THE SKIN BEIERSDORF AG (DE) 2019-06-12 — — EP disclosed
EP-2968100-B1 COMBINATION OF ALKYLAMIDOTHIAZOLES AND PRESERVATIVES BEIERSDORF AG (DE) 2019-04-10 — — EP disclosed
US-10245252-B2 Use of alkylamidothiazoles in cosmetic or dermatological preparations for the prophylaxis or treatment of sensitive skin BEIERSDORF AG (DE) 2019-04-02 — — US disclosed
EP-2969028-B1 COMPOSITIONS OF ALKYLAMIDOTHIAZOLES AND UV FILTER SUBSTANCES BEIERSDORF AG (DE) 2018-05-09 — — EP disclosed
EP-3176156-A1 ALKYLAMIDOTHIAZOLES, COSMETIC AND DERMATOLOGICAL PREPARATIONS CONTAINING THEM, AND THEIR USE FOR THE TREATMENT AND PROPHYLAXIS OF UNWANTED PIGMENTATION OF THE SKIN Beiersdorf AG (DE) 2017-06-07 — — EP disclosed
US-9610234-B2 Combinations of alkylamidothiazoles and preservatives BEIERSDORF AG (DE) 2017-04-04 — — US disclosed
EP-2758381-B1 ALKYLAMIDOTHIAZOLES, COSMETIC AND DERMATOLOGICAL PREPARATIONS CONTAINING THEM, AND THEIR USE FOR THE TREATMENT AND PROPHYLAXIS OF UNWANTED PIGMENTATION OF THE SKIN BEIERSDORF AG (DE) 2017-03-01 — — EP disclosed
US-9533963-B2 Alkylamidothiazoles, cosmetic or dermatological preparations containing said alkylamidothiazoles, and use thereof to combat or prevent undesired pigmentation of the skin BEIERSDORF AG (DE) 2017-01-03 — — US disclosed
US-20160324832-A1 USE OF ALKYLAMIDOTHIAZOLES IN COSMETIC OR DERMATOLOGICAL PREPARATIONS FOR THE PROPHYLAXIS OR TREATMENT OF SENSITIVE SKIN BEIERSDORF AG (DE) 2016-11-10 — — US disclosed
WO-2014139741-A1 COMBINATIONS OF ALKYLAMIDOTHIAZOLES AND CYCLODEXTRINS BEIERSDORF AG (DE) 2014-09-18 — — WO disclosed
WO-2014139759-A1 COMPOSITIONS CONSISTING OF ALKYLAMIDOTHIAZOLES AND UV-FILTER SUBSTANCES BEIERSDORF AG (DE) 2014-09-18 — — WO disclosed
WO-2014139758-A1 COMPOSITIONS CONSISTING OF ALKYLAMIDOTHIAZOLES AND AROMATIC SUBSTANCES BEIERSDORF AG (DE) 2014-09-18 — — WO disclosed
EP-2758383-A1 AROMATIC AMIDOTHIAZOLES, COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID AROMATIC AMIDOTHIAZOLES, AND USE THEREOF TO COMBAT OR PREVENT UNDESIRED PIGMENTATION OF THE SKIN Beiersdorf AG (DE) 2014-07-30 — — EP disclosed
EP-2758381-A1 ALKYLAMIDOTHIAZOLES, COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID ALKYLAMIDOTHIAZOLES, AND USE THEREOF TO COMBAT OR PREVENT UNDESIRED PIGMENTATION OF THE SKIN Beiersdorf AG (DE) 2014-07-30 — — EP disclosed
EP-2758382-A1 HETEROCYCLOCARBONYLAMINOTHIAZOLES, COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID HETEROCYCLOCARBONYLAMINOTHIAZOLES, AND USE THEREOF TO COMBAT OR PREVENT UNDESIRED PIGMENTATION OF THE SKIN Beiersdorf AG (DE) 2014-07-30 — — EP disclosed
US-20140121250-A1 ALKYLAMIDOTHIAZOLES, COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID ALKYLAMIDOTHIAZOLES, AND USE THEREOF TO COMBAT OR PREVENT UNDESIRED PIGMENTATION OF THE SKIN BEIERSDORF AG (DE) 2014-05-01 — — US disclosed
WO-2013041526-A1 ALKYLAMIDOTHIAZOLES, COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID ALKYLAMIDOTHIAZOLES, AND USE THEREOF TO COMBAT OR PREVENT UNDESIRED PIGMENTATION OF THE SKIN BEIERSDORF AG (DE) 2013-03-28 — — WO disclosed
WO-2013041537-A1 HETEROCYCLOCARBONYLAMINOTHIAZOLES, COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID HETEROCYCLOCARBONYLAMINOTHIAZOLES, AND USE THEREOF TO COMBAT OR PREVENT UNDESIRED PIGMENTATION OF THE SKIN BEIERSDORF AG (DE) 2013-03-28 — — WO disclosed
WO-2013041535-A1 AROMATIC AMIDOTHIAZOLES, COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID AROMATIC AMIDOTHIAZOLES, AND USE THEREOF TO COMBAT OR PREVENT UNDESIRED PIGMENTATION OF THE SKIN BEIERSDORF AG (DE) 2013-03-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140121250-A1 ALKYLAMIDOTHIAZOLES, COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID ALKYLAMIDOTHIAZOLES, AND USE THEREOF TO COMBAT OR PREVENT UNDESIRED PIGMENTATION OF THE SKIN TYR, PAH, NAT1 KDM4E 2444/4885MAPT 3035/4885KMT2A 1259/4885
US-10245252-B2 Use of alkylamidothiazoles in cosmetic or dermatological preparations for the prophylaxis or treatment of sensitive skin CUTA, TYR, AADAC KDM4E 4027/4885MAPT 2167/4885KMT2A 1400/4885
US-20160324832-A1 USE OF ALKYLAMIDOTHIAZOLES IN COSMETIC OR DERMATOLOGICAL PREPARATIONS FOR THE PROPHYLAXIS OR TREATMENT OF SENSITIVE SKIN CUTA, TYR, AADAC KDM4E 4027/4885MAPT 2167/4885KMT2A 1400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback